- Home
- BMRN vs LSCC Comparison
BMRN vs LSCC Comparison
Compare BMRN & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- LSCC
- Stock Information
- Founded
- BMRN 1996
- LSCC 1983
- Country
- BMRN United States
- LSCC United States
- Employees
- BMRN N/A
- LSCC N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- LSCC Semiconductors
- Sector
- BMRN Health Care
- LSCC Technology
- Exchange
- BMRN Nasdaq
- LSCC Nasdaq
- Market Cap
- BMRN 11.1B
- LSCC 9.8B
- IPO Year
- BMRN 1999
- LSCC 1989
- Fundamental
- Price
- BMRN $54.65
- LSCC $71.36
- Analyst Decision
- BMRN Buy
- LSCC Strong Buy
- Analyst Count
- BMRN 20
- LSCC 11
- Target Price
- BMRN $92.21
- LSCC $68.73
- AVG Volume (30 Days)
- BMRN 2.2M
- LSCC 2.6M
- Earning Date
- BMRN 10-28-2025
- LSCC 11-03-2025
- Dividend Yield
- BMRN N/A
- LSCC N/A
- EPS Growth
- BMRN 154.69
- LSCC N/A
- EPS
- BMRN 3.40
- LSCC 0.23
- Revenue
- BMRN $3,063,608,000.00
- LSCC $488,631,000.00
- Revenue This Year
- BMRN $13.35
- LSCC $3.96
- Revenue Next Year
- BMRN $9.18
- LSCC $19.53
- P/E Ratio
- BMRN $16.09
- LSCC $311.70
- Revenue Growth
- BMRN 18.36
- LSCC N/A
- 52 Week Low
- BMRN $52.48
- LSCC $34.69
- 52 Week High
- BMRN $73.51
- LSCC $76.62
- Technical
- Relative Strength Index (RSI)
- BMRN 47.87
- LSCC 55.79
- Support Level
- BMRN $53.19
- LSCC $71.89
- Resistance Level
- BMRN $54.50
- LSCC $75.22
- Average True Range (ATR)
- BMRN 1.20
- LSCC 2.54
- MACD
- BMRN 0.29
- LSCC -0.37
- Stochastic Oscillator
- BMRN 62.43
- LSCC 38.36
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About LSCC Lattice Semiconductor Corporation
Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.